Do you want to read an article? Please log in or register.
Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-β1/Smad signaling pathway
Pulmonary Hypertension
Related content
RECOMMENDED
Further Publications
Dual αvβ6 and αvβ1 Inhibition Over 12 Weeks Reduces Active Type 1 Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Montesi SB, Cosgrove GP, Turner SM, Zhou IY, Efthimiou N, Susnjar A, Catana C, Fromson C, Clark A, Decaris M, Barnes CN, Lefebvre ÉA, Caravan P
doi: 10.1164/rccm.202410-1934OC
ERS 2024
Pulmonary Hypertension
Activin signaling inhibitors in the treatment landscape of pulmonary arterial hypertension
RECOMMENDED
Pulmonary Hypertension
Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Smits AJ, Isebia K, Combee-Duffy C, van der Wal S, Nossent EJ, Boonstra A, Vonk-Noordegraaf A, Bogaard HJ, Serné EH
doi: 10.1038/s41598-024-69017-y
COMMENTED
Pulmonary Hypertension
Effects of β-blockers on the Outcomes in Patients with Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: a Multicenter Prospective Cohort Study (BNP-PL)
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Waligóra M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, Chrzanowski Ł, Błaszczak P, Jaguszewski M, Kuśmierczyk B, Ptaszyńska K, Grześk G, Mizia-Stec K, Malinowska E, Peregud-Pogorzelska M, Lewicka E, Tomaszewski M, Jacheć W, Florczyk M, Mroczek E, Gąsior Z, Pawlak A, Betkier-Lipińska K, Pruszczyk P, Widejko K, Zabłocka W, Kopeć G
doi: 10.1016/j.chest.2024.10.051
Pulmonary Hypertension
Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet Respir Med
GBD 2021 Pulmonary Arterial Hypertension Collaborators
doi: 10.1016/S2213-2600(24)00295-9
RECOMMENDED
Pulmonary Hypertension
Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant
Chiu S, Bunclark K, Appenzeller P, Ghani H, Taboada D, Sheares K, Toshner M, Pepke-Zaba J, Cannon J, Taghavi F, Tsui S, Ng C, Jenkins DP
doi: 10.1016/j.healun.2024.09.005
RECOMMENDED
Pulmonary Hypertension
Epidemiology of supplemental oxygen in patients with pulmonary hypertension
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respirology
Torres-Castro R, Hinojosa W, Martínez-Meñaca A, Sala Llinas E, Jiménez Arjona J, Rueda Soriano J, Aurtenetxe A, Barberà JA, Escribano-Subías P, Blanco I, REHAP Investigators
doi: 10.1111/resp.14821
RECOMMENDED
Pulmonary Hypertension
Management of pulmonary hypertension in special conditions
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Preston IR, Howard LS, Langleben D, Lichtblau M, Pulido T, Souza R, Olsson KM
doi: 10.1183/13993003.01180-2024
Pulmonary Hypertension
Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan
Adv Ther
Vizza CD, Klok R, Harley J, Small M, Scott M, Lautsch D, White RJ
doi: 10.1007/s12325-024-03026-1